Your session is about to expire
← Back to Search
Accelerated TMS for Depression
Study Summary
This trial will evaluate if an accelerated schedule of theta-burst stimulation using a transcranial magnetic stimulation device can help treat people with depression that has not responded to other treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have access to psychiatric care before and after the study.My mood symptoms have not worsened by 30% or more recently.I can get rTMS treatment after the study ends.I've had more than 8 ECT sessions without improvement.I have a history of serious brain or nerve conditions.I have a stable anxiety disorder but no other major psychiatric conditions requiring treatment.My treatment's intensity is more than 65% of the maximum level.You have or had a mental health condition called psychotic disorder or bipolar disorder.You have a serious borderline personality disorder.I have a hormone-related condition that is untreated or not fully treated.You should not significantly change your consumption of caffeine-containing products like coffee, tea, soda, or chocolate during the study.I have never undergone TMS therapy.I can avoid alcohol for 24 hours before MRI and TMS sessions and understand tobacco use is restricted.I have been on a stable antidepressant regimen for 6 weeks and will continue it during the study.You are pregnant.You cannot have a magnetic resonance imaging (MRI) scan because you have metal objects in your body that can be affected by the magnetic field.You cannot have participated in another experimental treatment during the study period.I have used ketamine or had ECT for depression in the last 4 weeks.I have been diagnosed with Major Depressive Disorder.I am between 22 and 65 years old.The person in charge of the study thinks that you have a condition that may affect the study or put you at risk.My medical records show I have hard-to-treat depression, as scored by a specific test.You have a drug or alcohol addiction or are currently experiencing withdrawal symptoms.You have been diagnosed with either intellectual disability or autism spectrum disorder.I do not have metal implants in my head, a history of seizures, or known brain lesions.You have had thoughts of hurting or killing yourself or attempted suicide within the past year.
- Group 1: Sham TBS-DLPFC
- Group 2: Active TBS-DLPFC
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this clinical trial actively seeking participants?
"The clinical trial is actively seeking participants, as reported on the government-hosted website. It was first uploaded to the platform on June 15th 2021 and its information has been updated most recently on May 5th 2022."
Are persons below the age of sixty capable of participating in this research?
"This medical trial seeks patients aged between 22 and 65. There are 177 studies for those under the legal age of consent and 859 for seniors who exceed that upper limit."
How many individuals are partaking in this medical experiment?
"Affirmative. Clinicaltrials.gov records show that this clinical trial, which was first published on June 15th 2021, is presently looking for participants. About 100 patients need to be enrolled from a single medical centre."
Do I meet the criteria to enroll in this experiment?
"This medical study is looking for 100 people who fit the following criteria: has been diagnosed with Major Depressive Disorder, aged between 22 and 65 years old, able to read and comprehend written English instructions, willing to comply with all procedures of the experiment, a history of treatment-resistance as per Maudsley Staging Method (MSM3), MADRS score of 20 or higher at screening visit 1 , no prior experience with TMS treatments , access to ongoing psychiatric care before and after completion of the study , have an active antidepressant therapeutic plan in place 6 weeks prior to enrolment that must be maintained throughout duration of trial,,and"
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Share this study with friends
Copy Link
Messenger